Site map
An overview of the available content on this site. Keep the pointer still over an item for a few seconds to get its description.
- Primary care
- Care homes
- Safety information for secondary care
- Ambulatory Care, 111 Hubs and Health Trusts
- Participating GP Practices
- Pharmacies
- Substantial Amendment 12
- PRINCIPLE Trial Online Prescreening
- Substantial Amendment 13
- Substantial Amendment 16
- Substantial Amendment 17
- Substantial Amendment 19
- Substantial Amendment 20
- Letter from Chief Medical Officers encourages participation in COVID-19 trials, including PRINCIPLE
- National priority COVID-19 trial recruits first patients
- PRINCIPLE Trial calls on UK primary care to support patient recruitment
- PRINCIPLE trial suspends hydroxychloroquine, continues with focus on azithromycin and other drugs
- PRINCIPLE trial rolled out across UK homes and communities
- GP practices urged to join COVID-19 research
- PRINCIPLE and ZOE partner to widen access to trial
- PRINCIPLE Trial to strengthen Black, Asian and minority ethnic community participation
- Accessibility
- PRINCIPLE Trial of COVID-19 treatments recruits 1000th participant
- Britain’s most influential Hindu temple spreads awareness of the PRINCIPLE trial among Indian community
- Two major pharmacy chains join PRINCIPLE Trial
- Inhaled corticosteroids to be investigated as a possible treatment for Covid-19 in national PRINCIPLE Trial
- De Montford University Leicester students to support PRINCIPLE trial recruitment
- Azithromycin and doxycycline are not generally effective against COVID-19 in patients treated at home, shows PRINCIPLE trial
- PRINCIPLE COVID-19 treatments trial widens to under 50s and adds colchicine
- Favipiravir to be investigated as a possible COVID-19 treatment for at-home recovery in the PRINCIPLE trial
- Asthma drug budesonide shortens recovery time in non-hospitalised patients with COVID-19
- Ivermectin to be investigated in adults aged 18+ as a possible treatment for COVID-19 in the PRINCIPLE trial
- PRINCIPLE trial 'highly commended' for innovative use of health data